327 filings
Page 4 of 17
8-K
50sg4at1y9m9wxobtuoc
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:12pm
8-K
jcn8vceyf52m534e
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:11pm
8-K
m6i uzp6wyxepaxv48ol
19 Jul 21
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
12:00am
S-8
mnjq5ouut2qhue9zoj78
25 Jun 21
Registration of securities for employees
4:31pm
8-K
49rf pwbbun3xgx4p99
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
dn94y
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
8-K
m2vm4d 82aruyzbcd
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
9mv5vrs3
10 May 21
Definitive proxy
4:06pm
10-Q
x3qkb4d2nj2
6 May 21
Quarterly report
4:14pm
8-K
z299evt 22eo3
6 May 21
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
4:08pm
10-K/A
ojk1ixo9srylt
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
m2akrs
27 Apr 21
Preliminary proxy
4:32pm
8-K
agx5c9kk5ybnzk9ktpcx
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
S-8
wzx7modrzre
24 Feb 21
Registration of securities for employees
4:28pm
8-K
e27gy7x
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
rtddrf8n7nvhb
24 Feb 21
Annual report
4:09pm
8-K
e5gl7l0uigcngw
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
djuzvyol
30 Dec 20
Material Change Report
5:30pm
6-K
egoqruxorsmwokg
21 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
4:05pm